A carregar...
Pretreatment and on-treatment predictors of viral breakthrough in lamivudine therapy for chronic hepatitis B
PURPOSE: There are remarkable advances in the treatment of chronic hepatitis B (CHB) in the last few years. Unfortunately, prolonged antiviral treatment is associated with increasing risk of drug resistance/viral breakthrough (VBT), which may lead to flare-up and rapid decompensation. We have design...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer-Verlag
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2716900/ https://ncbi.nlm.nih.gov/pubmed/19669325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-008-9095-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|